Form 4: D. Keith Grossman Reports Acquisition of Nevro Corp. Stock Units
SEC Form 4 Filing
Director D. Keith Grossman acquired 19,169 restricted stock units of Nevro Corp. on May 23, 2024, according to a Form 4 filing.
Summary
- D. Keith Grossman, a director of Nevro Corp., filed a Form 4 with the SEC.
- On May 23, 2024, Grossman acquired 19,169 restricted stock units (RSUs) of Nevro Corp.
- These RSUs will vest on the earlier of May 23, 2025, or the next Annual Meeting following May 23, 2024, contingent upon continued service to the Issuer.
- The price of the acquired stock units was $0.
- Following the transaction, Grossman beneficially owns 230,613 shares of Nevro Corp., including 41,073 RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock units by a director can be seen as a sign of confidence, but it's a routine transaction.
Positives
- The acquisition of RSUs by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The vesting of the RSUs is contingent upon the Reporting Person's continued service to the Issuer, suggesting an incentive for continued involvement with the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. This filing indicates a director's acquisition of company stock, which is a common occurrence.
Comparison to Industry Standards
- Insider transactions are common across publicly traded companies, and the reporting requirements are standardized by the SEC.
- The size and frequency of insider transactions can vary widely depending on the company's size, industry, and compensation practices.
- Comparing Grossman's holdings and transactions to those of directors at similar medical device companies like Medtronic or Boston Scientific could provide additional context.
Stakeholder Impact
- The acquisition of RSUs by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Acquisition of 19,169 restricted stock units. |
| 05/23/2024 | Date of earliest transaction. |
| 05/23/2025 | RSUs vest on the earlier of this date or the next Annual Meeting following May 23, 2024. |
| 05/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.